We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.32B
AUM Growth
+$18.4M
Cap. Flow
+$63.1M
Cap. Flow %
4.78%
Top 10 Hldgs %
33.66%
Holding
527
New
34
Increased
323
Reduced
125
Closed
25

Top Buys

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$29.1M
2
GLD icon
SPDR Gold Trust
GLD
+$19.8M
3
WMT icon
Walmart Inc
WMT
+$17M
4
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$13.8M
5
AMAT icon
Applied Materials
AMAT
+$4.96M

Top Sells

Rank Stock Value
1
UGL icon
ProShares Ultra Gold
UGL
+$12.5M
2
AZN icon
AstraZeneca
AZN
+$8.14M
3
AVGO icon
Broadcom
AVGO
+$5.93M
4
MSFT icon
Microsoft
MSFT
+$4.33M
5
APH icon
Amphenol
APH
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 35.21%
2 Healthcare 22.82%
3 Communication Services 11.05%
4 Consumer Discretionary 8.42%
5 Consumer Staples 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DBVT
401
DBV Technologies
DBVT
$889M
$104K 0.01%
+5,000
New +$104K
IRWD icon
402
Ironwood Pharmaceuticals
IRWD
$714M
$102K 0.01%
28,936
+2,428
+9% +$9.95K
SLDB icon
403
Solid Biosciences
SLDB
$971M
$99.5K 0.01%
13,826
+1,131
+9% +$7.27K
TMDX icon
404
Transmedics
TMDX
$3.02B
$99.4K 0.01%
1,000
– –
ALLO icon
405
Allogene Therapeutics
ALLO
$714M
$97.3K 0.01%
39,880
+3,260
+9% +$6.53K
TNDM icon
406
Tandem Diabetes Care
TNDM
$1.63B
$95.8K 0.01%
5,000
-3,000
-38% -$65.2K
CRMD icon
407
CorMedix
CRMD
$557M
$94.9K 0.01%
13,982
+1,143
+9% +$8.45K
ZVRA icon
408
Zevra Therapeutics
ZVRA
$679M
$93.1K 0.01%
9,990
+816
+9% +$7.36K
PRTA icon
409
Prothena Corp
PRTA
$475M
$92.9K 0.01%
9,553
+781
+9% +$7.16K
CMPS
410
Compass Pathways
CMPS
$1.97B
$92.5K 0.01%
16,735
+1,382
+9% +$9.29K
BHVN icon
411
Biohaven
BHVN
$2.17B
$91.4K 0.01%
10,800
+2,800
+35% +$30.6K
FULC icon
412
Fulcrum Therapeutics
FULC
$284M
$90.7K 0.01%
11,819
+3,000
+34% +$27.8K
IVVD icon
413
Invivyd
IVVD
$216M
$89.9K 0.01%
69,178
+24,021
+53% +$44.1K
AQST icon
414
Aquestive Therapeutics
AQST
$531M
$89.8K 0.01%
21,650
+1,770
+9% +$7.18K
LI icon
415
Li Auto
LI
$12.2B
$89.2K 0.01%
5,000
-5,000
-50% -$87.3K
IVA
416
Inventiva
IVA
$1.11B
$88.8K 0.01%
+16,000
New +$97.5K
KYTX icon
417
Kyverna Therapeutics
KYTX
$489M
$87.5K 0.01%
10,138
+3,001
+42% +$25K
KMDA icon
418
Kamada
KMDA
$397M
$87.2K 0.01%
10,236
+837
+9% +$7.04K
RIGL icon
419
Rigel Pharmaceuticals
RIGL
$782M
$87.1K 0.01%
3,221
+263
+9% +$8.84K
LRMR icon
420
Larimar Therapeutics
LRMR
$454M
$86.7K 0.01%
19,270
+5,323
+38% +$21.3K
UPB
421
Upstream Bio Inc
UPB
$378M
$86.3K 0.01%
9,590
+784
+9% +$14.1K
TRDA icon
422
Entrada Therapeutics
TRDA
$299M
$85.7K 0.01%
6,794
+566
+9% +$6.49K
FDMT icon
423
4D Molecular Therapeutics
FDMT
$621M
$84.3K 0.01%
9,052
-258
-3% -$2.25K
AXGN icon
424
Axogen
AXGN
$2.67B
$82.8K 0.01%
2,500
-500
-17% -$16.3K
ACRS icon
425
Aclaris Therapeutics
ACRS
$860M
$80.3K 0.01%
21,401
+3,746
+21% +$12.6K
15 16
17
18 19

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q1 2026 Portfolio in Review

As of Q1 2026, China Universal Asset Management Company held 527 positions worth $1.32B, up 1.4% from $1.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

China Universal Asset Management Company deployed $63.1M of net new capital in Q1 2026, opening 34 new positions and adding to 323 existing holdings. Its largest new stake was TJX Companies: 13,200 shares worth $2.11M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was ProShares Ultra Gold, an estimated $12.5M trimmed.

  • China Universal Asset Management Company's largest Q1 2026 buy was TJX Companies: 13,200 shares worth $2.11M.
  • China Universal Asset Management Company added most to iShares Gold Trust in Q1 2026, an estimated $29.1M increase.
  • China Universal Asset Management Company's biggest Q1 2026 reduction was ProShares Ultra Gold, cutting an estimated $12.5M.
  • China Universal Asset Management Company fully exited ServiceNow in Q1 2026, selling an estimated $2.5M.
  • China Universal Asset Management Company's ten largest holdings make up 34% of its $1.32B portfolio in Q1 2026.
  • China Universal Asset Management Company opened 34 new positions and closed 25 in Q1 2026.
  • China Universal Asset Management Company's portfolio value rose 1.4% quarter-over-quarter to $1.32B.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.